Federal contract award
FA486126F0084
ONCOTYPE DX CANCER TESTING (6 MONTH EXTENSION)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | FA4861 99 CONS LGC |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | FA486121D0004 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $41.9K |
| Current contract value | $41.9K |
| Potential contract value / ceiling | $41.9K |
| Start date | Mar 19, 2026 |
| Current end date | Sep 15, 2026 |
| Potential end date | Sep 15, 2026 |
| Latest award activity | Mar 19, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 19, 2026 | 0 | $41.9K | ONCOTYPE DX CANCER TESTING (6 MONTH EXTENSION) |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.